A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). The ganirelix dose-finding study group
Gespeichert in:
Ort, Verlag, Jahr:
1998
Enthalten in:
Human reproduction (Oxford, England), 13/11(1998-11), 3023-3031
Format:
Artikel (online)
Online Zugang: